Abstract:Monoterpene indole alkaloids (MIAs) are a class of natural products comprised of thousands of structurally unique bioactive compounds with significant therapeutic values. Due to difficulties associated with isolation from native plant species and organic synthesis of these structurally complex molecules, microbial production of MIAs using engineered hosts are highly desired. In this work, we report the engineering of fully integrated Saccharomyces cerevisiae strains that allow de novo access to strictosidine, the universal precursor to thousands of MIAs at 30-40 mg/L. The optimization efforts were based on a previously reported yeast strain that is engineered to produce high titers of the monoterpene precursor geraniol through compartmentalization of mevalonate pathway in the mitochondria. Our approaches here included the use of CRISPR-dCas9 interference to identify mitochondria diphosphate transporters that negatively impact the titer of the monoterpene, followed by genetic inactivation; the overexpression of transcriptional regulators that increase cellular respiration and mitochondria biogenesis. Strain construction included the strategic integration of genes encoding both MIA biosynthetic and accessory enzymes into the genome under a variety of constitutive and inducible promoters. Following successful de novo production of strictosidine, complex alkaloids belonging to heteroyohimbine and corynantheine families were reconstituted in the host with introduction of additional downstream enzymes. We demonstrate that the serpentine/alstonine pair can be produced at ∼5 mg/L titer, while corynantheidine, the precursor to mitragynine can be produced at ∼1 mg/L titer. Feeding of halogenated tryptamine led to the biosynthesis of analogs of alkaloids in both families. Collectively, our yeast strain represents an excellent starting point to further engineer biosynthetic bottlenecks in this pathway and to access additional MIAs and analogs through microbial fermentation. One sentence summary: An Saccharomyces cerevisiae-based microbial platform was developed for the biosynthesis of monoterpene indole alkaloids, including the universal precursor strictosidine and further modified heteroyohimbine and corynantheidine alkaloids.

Microbial synthesis of sedoheptulose from glucose by metabolically engineered Corynebacterium glutamicum

Enzymatic Synthesis of Oligosaccharides and Conversion to Glycolipids

Combinatorial Metabolic Engineering of Saccharomyces Cerevisiae for Improved Production of 7-Dehydrocholesterol

Systematic Engineering of Saccharomyces cerevisiae Chassis for Efficient Flavonoid-7- O -Disaccharide Biosynthesis

Microbial synthesis of the plant natural product precursor p-coumaric acid with Corynebacterium glutamicum

Advances in Metabolic Engineering of Saccharomyces Cerevisiae for Terpenoids Biosynthesis

Metabolic engineering of Saccharomyces cerevisiae for high-level production of gastrodin from glucose

Combinatorial metabolic engineering of Bacillus subtilis enables the efficient biosynthesis of isoquercitrin from quercetin

D -Sedoheptulose-7-phosphate is a Common Precursor for the Heptoses of Septacidin and Hygromycin B

Engineered Saccharomyces cerevisiae for biosynthesis of plant triterpenoids

Metabolic Engineering of Microorganisms for the Production of Flavonoids

Metabolic engineering of Saccharomyces cerevisiae for chelerythrine biosynthesis

Metabolic Engineering of Shikimic Acid-Producing Corynebacterium glutamicum From Glucose and Cellobiose Retaining Its Phosphotransferase System Function and Pyruvate Kinase Activities

Metabolic Engineering of Corynebacterium glutamicum for the Production of Flavonoids and Stilbenoids

Engineered biosynthesis of plant heteroyohimbine and corynantheine alkaloids in Saccharomyces cerevisiae

Constructing Microbial Hosts for the Production of Benzoheterocyclic Derivatives

Biological synthesis of coumarins in Escherichia coli

Targeted Discovery of Glycosylated Natural Products by Tailoring Enzyme-Guided Genome Mining and MS-Based Metabolome Analysis

High-level sustainable production of complex phenylethanoid glycosides from glucose through engineered yeast cell factories

Dissection Of The Glycosylation In The Biosynthesis Of The Heptadecaglycoside Antibiotic Saccharomicin A

De novo artificial synthesis of hexoses from carbon dioxide